Skip to main content
Top

Cancer Causes & Control

Issue 12/2019

Content (11 Articles)

Brief Report

Racial disparities of liver cancer mortality in Wisconsin

Amin Bemanian, Laura D. Cassidy, Raphael Fraser, Purushottam W. Laud, Kia Saeian, Kirsten M. M. Beyer

Glioblastoma Original Paper

Racial differences in brain cancer characteristics and survival: an analysis of SEER data

Julie A. Bytnar, Jie Lin, Craig D. Shriver, Kangmin Zhu

Prostate Cancer Original Paper

Body size and dietary risk factors for aggressive prostate cancer: a case–control study

Mikaela Pal, Allison M. Hodge, Nathan Papa, Robert J. MacInnis, Julie K. Bassett, Damien Bolton, Ian D. Davis, Jeremy Millar, Dallas R. English, John L. Hopper, Gianluca Severi, Melissa C. Southey, Roger L. Milne, Graham G. Giles

Colorectal Cancer Original Paper

Correlates of poor adherence to a healthy lifestyle among a diverse group of colorectal cancer survivors

Cindy K. Blair, Jean A. McDougall, Vi K. Chiu, Charles L. Wiggins, Ashwani Rajput, Elizabeth M. Harding, Anita Y. Kinney

Opioids Original Paper

Changes in use of opioid therapy after colon cancer diagnosis: a population-based study

Lu Chen, Jessica Chubak, Onchee Yu, Gaia Pocobelli, Rebecca A. Ziebell, Erin J. Aiello Bowles, Monica M. Fujii, Andrew T. Sterrett, Jennifer M. Boggs, Andrea N. Burnett-Hartman, Debra P. Ritzwoller, Rebecca A. Hubbard, Denise M. Boudreau

Prostate Cancer Original Paper

Polymorphisms in oxidative stress pathway genes and prostate cancer risk

Zhenzhen Zhang, Duo Jiang, Chi Wang, Mark Garzotto, Ryan Kopp, Beth Wilmot, Philippe Thuillier, Andy Dang, Amy Palma, Paige E. Farris, Jackilen Shannon

Open Access Hepatitis C Original Paper

Changing trends in liver cancer incidence by race/ethnicity and sex in the US: 1992–2016

Maxwell Salvatore, Jihyoun Jeon, Rafael Meza

Original Paper

Disparities in surgery for early-stage cancer: the impact of refusal

Joseph Rapp, Stephanie Tuminello, Naomi Alpert, Raja M. Flores, Emanuela Taioli

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine